The authors have proposed that the increased ADA1/ADA2 ratio in patients may lead to ADA1-mediated proinflammatory processes and to a decrease in ADA2-dependent neuroprotective effects, promoting multiple sclerosis [259]. This evidence concerns the gene ADA2 and multiple sclerosis.